BR100 Increased By (0.03%)
BR30 Decreased By (-0.13%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.08%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 56.17 Decreased By ▼ -1.15 (-2.01%)
BOP 30.10 Decreased By ▼ -0.02 (-0.07%)
CNERGY 12.92 Decreased By ▼ -0.06 (-0.46%)
CSIL 5.32 Increased By ▲ 0.01 (0.19%)
FCCL 51.90 Increased By ▲ 0.25 (0.48%)
FFL 14.52 Increased By ▲ 0.03 (0.21%)
FNEL 1.24 Increased By ▲ 0.03 (2.48%)
KEL 6.06 No Change ▼ 0.00 (0%)
KOSM 5.89 Increased By ▲ 0.05 (0.86%)
LOTCHEM 26.15 Decreased By ▼ -0.02 (-0.08%)
MLCF 91.36 Increased By ▲ 0.13 (0.14%)
NBP 163.90 Decreased By ▼ -0.29 (-0.18%)
NCPL 53.49 Increased By ▲ 0.31 (0.58%)
NPL 59.40 Increased By ▲ 0.28 (0.47%)
OGDC 312.70 Decreased By ▼ -0.69 (-0.22%)
PACE 9.71 Decreased By ▼ -0.06 (-0.61%)
PAEL 35.25 Increased By ▲ 0.01 (0.03%)
PIBTL 14.77 Increased By ▲ 0.06 (0.41%)
PPL 220.49 Decreased By ▼ -0.87 (-0.39%)
PRL 91.40 Increased By ▲ 0.18 (0.2%)
PTC 59.65 Increased By ▲ 0.46 (0.78%)
SSGC 23.48 Increased By ▲ 0.18 (0.77%)
TBL 8.83 Increased By ▲ 0.08 (0.91%)
TELE 7.65 Increased By ▲ 0.04 (0.53%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.40 Decreased By ▼ -0.16 (-1.27%)
TREET 21.77 Increased By ▲ 0.04 (0.18%)
TRG 56.09 Increased By ▲ 0.30 (0.54%)
World

Italy's Draghi dismisses China's COVID vaccine, casts doubt on Sputnik

  • "The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.
Published Updated
By

BRUSSELS: Italian Prime Minister Mario Draghi said China's anti-COVID vaccine did not fully work and questioned whether Russia's Sputnik jab would ever get approval from European regulators.

"The Chinese vaccine ... has shown itself not to be adequate. You can see that from Chile's experience of tackling the epidemic," Draghi told reporters at the end of a European Union summit.

Chile has relied heavily on the COVID-19 shot developed by China's Sinovac, but health authorities in the South American country have questioned how effective it is against more transmissible virus variants and are also looking into how long it remains effective once injected.

A study published in April said the Chinese vaccine proved minimally effective at preventing illness after one dose. With a second jab, it was 67% effective in preventing symptomatic infection, 85% effective in preventing hospitalizations and 80% in preventing deaths.

Draghi also questioned Russia's Sputnik vaccine.

The European Medicines Agency (EMA) had been expected to conclude its review of the Russian jab and issue a decision in May or June. However, approval was delayed because the makers missed a June 10 deadline to submit data, sources told Reuters earlier this month.

"The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.

Comments

Comments are closed for this article.